Intravenous (Iv) Solutions Market Size to grow by USD 4963 million between 2024-2028
According to a research report “ Intravenous (Iv) Solutions Market” by Type (Partial parenteral nutrition, Total parenteral nutrition) Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) Geography (Asia, North America, Europe, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4963 million, at a CAGR of 8.09% during the forecast period. The IV solutions market is experiencing significant growth due to the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular conditions. These diseases necessitate the use of IV solutions for the delivery of fluids, electrolytes, and medications to patients. According to the International Diabetes Federation (IDF), the global diabetes population is projected to reach 700 million by 2045. Diabetes patients require IV solutions for glucose management, making diabetes a key driver for market expansion. Additionally, the increasing incidence of cancer is further fueling market growth, as IV solutions are essential for chemotherapy administration..
Browse market data tables, figures, and in-depth TOC on “Intravenous (Iv) Solutions Market” by Type (Partial parenteral nutrition, Total parenteral nutrition) Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) Geography (Asia, North America, Europe, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Type, the Partial parenteral nutrition segment is projected to dominate the market size in 2024
The Intravenous (IV) Solutions market represents a significant business opportunity, driven by the increasing prevalence of chronic diseases and the growing demand for efficient and convenient medical treatments. Key players in this market offer a diverse range of solutions, including balanced electrolyte solutions, dextrose solutions, and nutritional solutions, to cater to various patient requirements. Market growth is further fueled by advancements in technology, which enable the production of sterile and customized IV solutions, ensuring patient safety and satisfaction.
By Distribution Channel, Hospital pharmacy segment is expected to hold the largest market size for the year 2024
The Intravenous (IV) Solutions market represents a significant segment within the healthcare industry, catering to the administration of essential nutrients, fluids, and medications directly into a patient's bloodstream. This market witnesses continuous growth due to increasing hospitalizations, rising prevalence of chronic diseases, and advancements in infusion technologies. Key players focus on innovation to offer a wide range of solutions addressing various therapeutic areas and patient needs.
Asia is forecasted to hold the largest market size by region in 2024
The Intravenous (IV) Solutions market represents a significant segment in the healthcare industry, catering to the administration of essential nutrients, fluids, and medications directly into the patient's bloodstream. This market witnesses consistent growth due to increasing hospitalizations, rising prevalence of chronic diseases, and technological advancements in infusion therapy. Key players focus on product innovation, strategic collaborations, and expanding their geographical presence to capitalize on these trends.
The Intravenous (Iv) Solutions Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The global Iv Solutions Market is witnessing significant growth due to the increasing worldwide cancer incidence, postoperative treatment requirements, intensive care needs, and the prevalence of spinal injuries, cardiovascular disorders, and low immunity levels. Parenteral nutrition products, including Iv solutions, play a crucial role in addressing malnutrition, especially in gastrointestinal disorders such as colorectal cancer, infection, and neurological diseases. These solutions provide essential vitamins, minerals, sugar, electrolytes, and water directly into the bloodstream, bypassing the gastrointestinal tract. Iv solutions are vital for managing various conditions, including gastrointestinal disorders, neurological conditions, and diseases affecting the cardiovascular system. They are also essential for preterm births and the geriatric population. Vitamin C is often added to Iv solutions to enhance their therapeutic benefits. The rising prevalence of these conditions and the increasing awareness of the importance of proper nutrition support drive the growth of the Iv Solutions Market.
Market Research Overview
The Intravenous (IV) Solutions market is witnessing significant growth due to the increasing worldwide cancer incidence, especially in colorectal, pancreatic, liver, gastric, esophageal, and gastrointestinal cancer patients. IV Solutions are essential in ambulatory surgery centers for postoperative treatment, intensive care, and spinal injuries, as well as in the management of cardiovascular disorders, low immunity levels, and gastrointestinal disorders. IV Solutions come in various forms, including irrigating, drug, blood, and nutritional solutions. The nutritional IV solutions contain vitamins, minerals, amino acids, and glutamine, which are crucial for patients with chronic diseases and malnutrition. Hydration, electrolyte balance, and blood transfusion are vital aspects of patient care, especially in critical illnesses, infections, dehydration, and geriatric, adult, and pediatric populations. The market comprises retail pharmacy and hospital pharmacy segments, with hospitals and clinics being the primary consumers. The IV Solutions market includes basic IV solutions, such as normal saline, hypertonic saline, and mixed solutions, as well as specialized IV solutions, such as parenteral nutrition products, trace elements, heparin, vitamins and minerals, amino acids, lactated ringer’s, dextran, and saline. Regulatory authorities and technical norms play a crucial role in the import and export analysis of IV Solutions. Factors such as a lack of awareness, complications, pain management, perioperative care, surgical procedures, home care settings, and nutritional support drive market growth. The market is expected to grow multi-pronged approaches, product portfolios, and patient care in regional markets. Complications, such as infections, are a concern, and pain management, perioperative care, and surgical procedures are significant applications for IV Solutions. The IV Solution compositions include vitamins, minerals, fats, proteins, and carbohydrates, which are administered using infusion pumps and IV catheters. Neonatal patients and patients with chronic diseases require specialized IV Solutions. Patient awareness and healthcare infrastructure are essential factors influencing market growth, along with healthcare expenditure and the increasing geriatric population.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
